Board summary
Key figures
32,565
Registered population
61.7% aged 18–64
16.3%
Aged 65+
ICB 18.8% · England 17.9%
27.1%
Ethnic minority (non-White)
21.0% Asian · England 9.6%
2.7%
In IMD quintile 1
ICB 0.8% · England 21.0%
~889
Core20 residents (est.)
Resident basis; registered basis ~871 · see page 3
4,573
Hypertension register
+8.29% in 3 yrs · England +5.60%
301
SMI register
30% of Woking's
409
COPD register
Reviews +9.34% in 3 yrs
Forecast to 2030
5,373
Hypertension patients, 2030
+800 on today
80.8%
QRISK ≥20% on statins, 2030
+7.39pp over 3 yrs
4.6%
Cancer prevalence, 2030
England 4.5%
Three things the board should see
Smoking cessation offers fell behind England.
Offers fell 5.5 pp over 2023 to 2025 to 85.5% (England +0.1 pp to 94.2%), which may reflect unverified recall capacity constraints.
Phone access diverges sharply across practices.
Easy phone contact is 29.0% at Goldsworth Park Health Centre (England 56.9%) against 67.0% at Sheerwater Health Centre, a 38.1 pp practice spread.
Heart failure reviews outpaced England's growth.
Annual heart failure reviews rose +24.2% over 2023 to 2025 (England +8.7%), reaching 83.5% against 78.5% in England and 79.9% in the ICB.
Population, age and ethnicity
Asian residents comprise 21.0% locally while young people make up 22.0% of patients
Across 32,565 registered patients, 22.0% (7,150) are aged 0-17, above Woking (21.3%), the ICB (20.4%), and England (19.6%). Patients aged 65+ account for 16.3% (5,322), above Woking (15.3%) but below the ICB (18.8%) and England (17.9%). Census estimates indicate 21.0% of usual residents are Asian / Asian British, exceeding Woking (14.2%), the ICB (7.7%), and England (9.6%). Sheerwater Health Centre has 26.7% aged 0-17 and a 27.9% Asian resident share. Ethnicity reflects Census usual residents, not GP registers.
Age profile
65+: ICB 18.8%, England 17.9%
Ethnicity
Older people · falls rows are Woking local-authority (LA) data, not PCN
| Measure | Local | South East | England | Period |
|---|---|---|---|---|
| Falls admissions, 65+, per 100,000 (Woking LA) | 1,854 | 2,018 | 1,958 | 2024/25 |
| Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN) | 74.6% | 82.2% | 81.9% | 2024/25 |
| Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN) | 57.2% | 57.8% | 57.4% | 2024/25 |
| Falls admissions, 65 to 79, per 100,000 (Woking LA) | 796 | 981 | 955 | 2024/25 |
| Falls deaths, all ages, per 100,000 (Woking LA) | 11.2 | 14.0 | 14.8 | 2022‑24 |
Deprivation and Core20
Core20 deprivation is 2.7% overall and concentrates at Goldsworth Park Health Centre
The PCN Core20 share is 2.7%, above Woking (1.5%) and the ICB (0.8%) but below England (21.0%), with an average IMD decile of 7.3. Modelled practice counts total 871, differing from 889 estimated resident Core20 persons. Concentration and workload align at Goldsworth Park Health Centre with 587 estimated Core20 patients (4.78% share), while Heathcot Medical Practice holds 284 (1.69%) and Sheerwater Health Centre records 0.0%. Outreach should focus on Goldsworth Park Health Centre where both Core20 share and patient volume are highest.
% of patients in IMD quintile 1, by practice
Dashed line: England 21.0% · right column: Core20 patients, registered basis
PLUS groups and inclusion health
PLUS groups and inclusion health
301
SMI register
0.88% recorded prevalence
178
Learning disability register
0.52% recorded prevalence
17
Care homes, 571 beds
In the PCN catchment
8.3%
Provide unpaid care
Woking, Census 2021
The PCN records 301 patients with severe mental illness (0.9% prevalence) and 178 on the learning disability register (0.5%), representing 30% and 29% of Woking's registers respectively, alongside 17 catchment care homes with 571 beds. With severe mental illness prevalence above the borough and ICB benchmarks (both 0.8%), sustaining routine annual physical health checks could be prioritised to protect these complex caseloads.
Severe mental illness: physical health checks
On the SMI register, 78.4% received a blood pressure check (England 83.4%), falling to 70.1% at Goldsworth Park Health Centre, while 77.6% had BMI recorded (England 82.1%). Lagging checks may leave physical risks unmonitored, which recall audits would test.
Clinical focus: hypertension and lipids
Clinical focus: hypertension and lipids
4,573
Hypertension register
+8.29%
Register growth, 3 yrs
Woking +6.51% · England +5.60%
−0.71pp
BP control, under 80
≤140/90 · −2.39pp aged 80+
+800
More patients by 2030
Forecast 5,373 (15.61%)
Hypertension case-finding and control
Hypertension recorded prevalence is 13.3% (4,573 patients), below England (15.2%) and NHS Surrey Heartlands ICB (14.3%), although the register grew +8.3% over three years (England +5.6%). Routine blood pressure monitoring fell 1.7% to 88.5% (England +3.6% to 90.0%), and BP control in patients aged 80+ fell 2.9% to 79.0% (England +2.2% to 81.2%), ranging from 74.8% at Goldsworth Park Health Centre to 84.6% at Sheerwater Health Centre. Observation periods between list size and registers are unconfirmed. Declining monitoring and older-age control may reflect recall shortfalls, which local audits would test.
Lipids and statins
Patients with QRISK ≥ 20% on lipid-lowering therapy reached 63.0%, with three-year growth of +13.3% (England +6.2% to 63.6%), while diabetes statin coverage is 69.9% (England 73.2%). Lower statin coverage in diabetic patients without cardiovascular disease may reflect treatment initiation gaps, which prescribing reviews would test.
| Measure | Items | Cost / item | ICB | England | Annual spend |
|---|---|---|---|---|---|
| Lipid-modifying, 2026 | 38,827 | £2.90 | £2.24 | £1.86 | £112,598 |
| Cardiovascular (all), 2025 | 51,982 | £5.16 | £4.74 | £3.33 | £268,227 |
In 2026, lipid-regulating drugs cost £2.90 per item across 38,827 items, exceeding England (£1.86), Woking (£2.50), and NHS Surrey Heartlands ICB (£2.24), representing £40,380 more than at England's unit cost. Higher unit costs across lipid-regulating items may reflect choice of agents rather than efficiency, which formulary reviews would test.
Clinical focus: respiratory, cancer register and children
Clinical focus: respiratory, cancer register and children
Respiratory
−1.09%
Asthma reviews, PCN 3-yr % change
+4.44%
Asthma reviews, England 3-yr % change
+0.77%
Asthma prevalence, PCN 3-yr % change
Asthma reviews fell 1.1% over three years (England +4.4%) to 63.5% (Woking 68.1%, England 65.7%), leaving about 660 of 1,798 register patients unreviewed, though QOF includes personalised care adjustments. Second-hand smoking recording for ages 6–19 is 73.5% (Woking 81.0%), and youth asthma prescribing is 766 per 1,000 (England 1,488). COPD reviews rose 9.3% over three years (England +2.8%) to 68.0% (England 76.4%). Review shortfalls may leave respiratory patients at risk of unmanaged symptoms, which practice review audits would test.
Cancer register and children's immunisation
Cancer prevalence is 3.5% (1,187 patients), below England (3.8%). At age 5, MMR dose 1 coverage reached 97.8%, but dose 2 was 87.9% (7.1 pp below the 95.0% target, cohort 91), creating a 9.9 pp gap. Same-cohort dose differences span 18.2 pp at Sheerwater Health Centre and 11.3 pp at Heathcot Medical Practice, though quarterly COVER data is cross-sectional. Second-dose drop-off may leave cohorts vulnerable to preventable outbreaks, which recall audits would test.
Dashed line: 95% national coverage target · solid tick: England
Early cancer diagnosis
Early cancer diagnosis
61.4%
Surrey Heartlands ICB, stage 1–2
55.3%
England, 2022
75%
National ambition by 2028
~650
Extra early-stage cases a year to reach the ambition
| Stage 1–2 share by cancer type, 2022 | Surrey Heartlands ICB | England | No usable stage | Staged cancers |
|---|---|---|---|---|
| Prostate | 65.7% | 53.2% | 18% | 1,044 |
| Breast | 88.2% | 85.4% | 27% | 798 |
| Bowel | 48.1% | 47.0% | 18% | 626 |
| Lung | 33.2% | 33.8% | 17% | 497 |
| Skin cancer | 89.8% | 87.8% | 19% | 384 |
In NHS Surrey Heartlands ICB (2022), 61.4% of cancers with known stage (2,955 of 4,810) were diagnosed at stage 1 or 2, rising 6 pp since 2013 (England 55.3%, national ambition 75.0% by 2028). Known stage was recorded for 67.7% of cancers (4,810 of 7,106), requiring about 650 extra early-stage cases yearly across the ICB. PCN cervical screening in women aged 25-49 is 60.3% (3-year change -2.8% over 2023 to 2025; England -1.0%), trailing the ICB (69.3%). Coverage is 58.6% at Goldsworth Park Health Centre, 60.2% at Heathcot Medical Practice, and 66.6% at Sheerwater Health Centre. Screening shortfalls may delay detection, making systematic recall a priority.
Cancer waits, diagnostics and community services
Cancer waits, diagnostics and community services
Cancer waits and diagnostics, Jul 2026 (provisional)
In July 2026 (provisional), Ashford and St Peter's Hospitals NHS Foundation Trust met the 28-day faster diagnosis standard at 85.5% (against the 75.0% standard; Frimley Health NHS Foundation Trust 87.9%, Royal Surrey NHS Foundation Trust 82.6%, NHS Surrey and Sussex Integrated Care Board 79.3%, England 79.3%). On the 62-day referral to treatment standard, the trust reached 76.4% against the 85.0% standard (Frimley Health 81.8%, Royal Surrey 84.5%, ICB 71.5%, England 71.2%). Diagnostic 6+ week waits across all tests were 23.1% (England 23.1%), with colonoscopy at 49.6% and gastroscopy at 56.7%.
| Pathways within standard (%) | Ashford and St Peter's | Royal Surrey | Frimley Health | Surrey and Sussex ICB | England |
|---|---|---|---|---|---|
| 28-day faster diagnosis (75%) | 85.53 | 82.62 | 87.95 | 79.29 | 79.32 |
| 31-day treatment (96%) | 94.21 | 96.43 | 92.89 | 90.45 | 92.50 |
| 62-day referral to treatment (85%) | 76.38 | 84.48 | 81.84 | 71.51 | 71.16 |
| Diagnostic waits over 6 weeks (%) | Ashford and St Peter's | Royal Surrey | Frimley Health | England |
|---|---|---|---|---|
| MRI | 0.09 | 0.00 | 12.85 | 21.40 |
| CT | 9.27 | 0.15 | 0.63 | 9.92 |
| Echocardiography | 0.97 | 1.55 | 3.35 | 28.48 |
| Colonoscopy | 49.61 | 0.00 | 22.84 | 30.83 |
| Gastroscopy | 56.74 | 0.00 | 7.43 | 29.02 |
| All 15 DM01 tests | 23.12 | 8.82 | 7.49 | 23.14 |
| Community services activity | Surrey residents | Surrey and Sussex ICB |
|---|---|---|
| Care contacts | 109,530 | 309,615 |
| Referrals | 28,700 | 66,930 |
| Patients with a contact | 33,510 | 85,660 |
Community services (residents of Surrey), Jun 2026 (provisional). Provisional experimental data for June 2026 shows 109,530 community care contacts and 66,060 care activities for Surrey residents, alongside 309,615 care contacts across NHS Surrey and Sussex Integrated Care Board. Adults aged 65+ accounted for 69.6% of Surrey contacts (76,215). These system-level counts reflect submitting providers, not PCN activity.
Practice variation and patient experience
Phone access spans 38.1 pp across practices while vaccination achievement spans 44.4 pp
In 2025/26, QOF overall achievement ranged from 82.2% at Goldsworth Park Health Centre to 94.7% at Heathcot Medical Practice (England 92.5%). Vaccination achievement spanned 44.4 pp, from 15.6% at Sheerwater Health Centre to 60.0% at Heathcot Medical Practice (England 55.2%). This disparity may reflect differing recall processes, though local administrative systems have not been audited.
GP Patient Survey by practice
| Practice | Responses | % in IMD Q1 | Phone easy | Request led to appt | Overall good |
|---|---|---|---|---|---|
| Heathcot Medical | 107 | 1.7 | 42.5% | 69.9% | 73.0% |
| Sheerwater | 106 | 0.0 | 67.0% | 63.4% | 71.8% |
| Goldsworth Park | 111 | 4.8 | 29.0% | 82.4% | 56.6% |
| England | — | ~21 | 56.9% | 71.6% | 76.7% |
Where the PCN lags
Twelve of 25 compared measures trail England over three years despite heart failure gains
Across 25 compared measures, 12 trail England's three-year change. Smoking cessation support offered fell 5.5 pp over 2023 to 2025 (England +0.1 pp) to 85.5% (England 94.2%). Asthma reviews fell 1.1% over three years (England +4.4%) to 63.5% (England 65.7%). Conversely, heart failure reviews rose +24.2% (England +8.7%) to 83.5% (England 78.5%), and QRISK ≥ 20% lipid therapy grew +13.3% (England +6.2%). The PCN could adapt call-and-recall workflows from heart failure to routine asthma and smoking reviews.
3-year change · PCN vs England
Bars show the direction and scale of relative change. Orange: PCN · Grey: England.
Smoking support (SMI)
Asthma reviews
Diabetes HbA1c control
Hypertension BP reading
BP control, 80+
Heart failure reviews
QRISK statin treatment
COPD reviews
What the data can't tell us: gaps and local assets
What the data can't tell us: gaps and local assets
| Local assets and voluntary sector | PCN | Woking | Asset | PCN | Woking |
|---|---|---|---|---|---|
| Care homes (catchment) | 17 (571 beds) | n/a | Schools (catchment) | 68 | n/a |
| Children's centres | 6 | 8 | Places of worship | 37 | 49 |
| Libraries | n/a | 1 | Homelessness support (VCS) | 0 | no data |
| Day centres (VCS) | 2 | 2 | Carers support groups (VCS) | 1 | 1 |
| Primary schools (LA maintained) | 1 | 2 | Primary academies | 15 | 19 |
| Special schools | 1 | 1 |
0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.
Options for the PCN
Options for the PCN
Each option in full
Option 1
Standardised annual asthma review recall
Asthma reviews fell 1.1% over 2023 to 2025 to 63.5% (England +4.4% to 65.7%; Woking +4.8% to 68.1%), leaving 657 of 1,798 register patients unreviewed. For discussion: the PCN could run a shared recall template across practices, offering flexible review slots and checking inhaler prescribing. Moderate effort to run.
Evidence base: the annual asthma review is the process gap between the register and outcomes.
Policy anchor: Core20PLUS5 chronic respiratory disease priority.
Option 2
Pre-school MMR second-dose recall
In Q1 2025/26, age-5 MMR coverage was 97.8% for dose 1 vs 87.9% for dose 2 (cohort 91; 9.9 pp difference), with dose 2 7.1 pp below the 95.0% target. Low cost, quick to run.
Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.
Policy anchor: 10 Year Health Plan, shift from sickness to prevention.
Option 3
SMI physical health check outreach
Across 301 SMI patients (0.9% prevalence, 30% of Woking's register), 12-month BP checks are 78.4% (England 83.4%, Woking 82.7%, ICB 83.5%), and 70.1% at Goldsworth Park Health Centre. For discussion: the PCN could run combined physical-check appointments, validate component coding, and raise shared pathways with mental health partners. Moderate effort to run.
Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.
Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.
Provenance and audit trail
Provenance and audit trail
Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.
| Recommendation | Indicator(s) | Policy anchor | Data level |
|---|---|---|---|
| Multilingual communication and outreach (p2) | Asian / Asian British | Neighbourhood health framework · Core20PLUS5 approach | PCN |
| Targeted Core20 outreach (p3) | Core20 cohort (IMD quintile 1) | Core20PLUS5 · 10YHP equity test | PCN |
| SMI physical check recall (p4) | SMI register with a BP check in the last 12 months | MHIS · From Harm to Hope | PCN |
| Hypertension recall and control audit (p5) | Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs) | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Pre-school MMR recall audit (p6) | MMR dose 2 coverage at age 5 | 10YHP sickness to prevention · 95% target | PCN |
| Cervical screening recall audit (p7) | Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs) | Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026 | PCN |
| Practice telephony and triage review (p9) | GPPS easy to contact the practice by phone | 10YHP, hospital to community | Practice |
| Option 1 · Standardised annual asthma review recall (p12) | Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) | Core20PLUS5 respiratory | PCN |
| Option 2 · Pre-school MMR second-dose recall (p12) | MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 5 | 10YHP sickness to prevention · 95% target | PCN |
| Option 3 · SMI physical health check outreach (p12) | Severe mental illness register · Severe mental illness: QOF prevalence · SMI register with a BP check in the last 12 months | MHIS · From Harm to Hope | PCN & Practice |
Data sources
Data sources
Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.
| Dataset | Level | Period | Used for |
|---|---|---|---|
| Coplug indicator tables: census, deprivation and QOF measures | PCN & Practice | 2023 to 2025, projected to 2030; 2023 to 2024 | Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 |
| MHCLG, Rough sleeping snapshot in England: autumn 2025 | Local authority | Autumn 2025 | Pages 2, 4 |
| OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) | PCN | 2024/25 | Pages 2, 4 |
| OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002) | Local authority | 2024/25; 2022-24 | Pages 2, 4 |
| ONS, Census 2021 TS039: provision of unpaid care (age-standardised) | Local authority | Census 2021 | Pages 2, 4 |
| QOF registers, prevalence and care processes (Coplug indicator tables) | Practice | 2023 to 2025, projected to 2030 | Pages 4, 5, 6, 7, 8, 10 |
| UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26 | PCN & Practice | Q1 2025/26 | Pages 4, 6 |
| UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026 | ICB | 2025/26 season to 28 Feb 2026 | Pages 4, 6 |
| NHS England, Cancer Waiting Times: July 2026 monthly time series with revisions | ICB & Provider | Jul 2026 (provisional) | Pages 7, 8 |
| NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental data | ICB & Local authority | Jun 2026 (provisional) | Pages 7, 8 |
| NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026 | Provider | Jul 2026 | Pages 7, 8 |
| National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022 | ICB | 2022 | Pages 7, 8 |
| NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted) | Practice | Survey Jan-Apr 2026 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domain | Practice | 2025/26 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domain | Practice | 2025/26 | Page 9 |
| Coplug indicator catalogue — definitions, cohorts, policy anchors | Reference | Current | Evidence-base lines, page 13 |
Methods, data-quality notes and limitations
Methods, data-quality notes and limitations
Methods
Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.
Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.
Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.
Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.
